Showing all 6 results

Show sidebar
Show 9 24 36

GALVUS 50MG Tabletten 60 Stk.(Vildagliptin)

€70.18
Clinical and pharmacological group: Oral hypoglycemic drug Pharmacotherapeutic group: Agents for the treatment of diabetes mellitus; hypoglycemic agents, except insulins; dipeptidyl peptidase-4 (DPP-4) inhibitors
Add to wishlist
Add to cart
Quick view

GALVUS 50MG Tabletten 90 Stk.(Vildagliptin)

€93.96
Clinical and pharmacological group: Oral hypoglycemic drug Pharmacotherapeutic group: Agents for the treatment of diabetes mellitus; hypoglycemic agents, except insulins; dipeptidyl peptidase-4 (DPP-4) inhibitors
Add to wishlist
Add to cart
Quick view
Sold out
Ultibro® Breezhaler® is intended for the maintenance treatment of patients with COPD.

ULTIBRO Breezhaler 85 µg/43 µg Hartk.m.Plv.z.Inh. (Glycopyrronium bromide + Indacaterol), 10

€0.00
Ultibro® Breezhaler® is intended for the maintenance treatment of patients with COPD.
Add to wishlist
Read more
Quick view
Ultibro® Breezhaler® is intended for the maintenance treatment of patients with COPD.

ULTIBRO Breezhaler 85 µg/43 µg Hartk.m.Plv.z.Inh. (Glycopyrronium bromide + Indacaterol), 30

€122.12
Ultibro® Breezhaler® is intended for the maintenance treatment of patients with COPD.
Add to wishlist
Add to cart
Quick view
Ultibro® Breezhaler® is intended for the maintenance treatment of patients with COPD.

ULTIBRO Breezhaler 85 µg/43 µg Hartk.m.Plv.z.Inh. (Glycopyrronium bromide + Indacaterol), 90

€329.89
Ultibro® Breezhaler® is intended for the maintenance treatment of patients with COPD.
Add to wishlist
Add to cart
Quick view
Symptomatic treatment of pain and inflammation.

Voltaren Resinat diclofenac–cholestyramine),100

€42.79
Symptomatic treatment of pain and inflammation.
Add to wishlist
Add to cart
Quick view